A Case of Rivaroxaban-Induced Acute Tubulointerstitial Nephritis

Files

Authors

Kali Gray, Corewell Health Fellow
Kelly Mercier, Corewell Health

Description

Direct oral anticoagulants have garnered increasing popularity over the past several years and have largely replaced the use of warfarin in the treatment of certain conditions such as atrial fibrillation and the prevention and treatment of thromboembolism.

Rivaroxaban is one of the most commonly used direct oral anticoagulants. It is 66% renally-cleared and a common side effect is renal impairment of which the pathophysiology has been unclear.

There have been case reports of rivaroxaban-induced acute tubulointerstitial nephritis. Here we present an additional case of acute tubulointerstitial nephritis, most likely caused by rivaroxaban.

Publication Date

5-9-2024

Disciplines

Nephrology

Recommended Citation

Gray K, Mercier. A case of rivaroxaban-induced acute tubulointerstitial nephritis. Presented at Corewell Health Hospital Farmington Hills 2024 Alvin Yarrows Research Day; 2024 May 9; Farmington Hills, MI.

Comments

2024 Alvin Yarrows Research Day at Corewell Health Hospital Farmington Hills, Farmington Hills, MI, May 9, 2024.